Impact of Supervised Exercise on One-Year Medication Use in Older Veterans with Multiple Morbidities.

Autor:	Pepin MJ; VA Health Care System, Durham, NC, USA., Valencia WM; Miami Healthcare System, FL, USA.; University of Miami, Miami, FL, USA., Bettger JP; Duke University Medical Center, Durham, NC, USA., Pearson M; VA Health Care System, Durham, NC, USA., Manning KM; VA Health Care System, Durham, NC, USA., Sloane R; Duke University Medical Center, Durham, NC, USA.; Center for Aging/ OAIC, Duke University, NC USA., Schmader KE; VA Health Care System, Durham, NC, USA.; Duke University Medical Center, Durham, NC, USA.; Center for Aging/ OAIC, Duke University, NC USA., Morey MC; VA Health Care System, Durham, NC, USA.; Duke University Medical Center, Durham, NC, USA.; Center for Aging/ OAIC, Duke University, NC USA.
Jazyk:	angličtina
Zdroj:	Gerontology & geriatric medicine [Gerontol Geriatr Med] 2020 Sep 19; Vol. 6, pp. 2333721420956751. Date of Electronic Publication: 2020 Sep 19 (Print Publication: 2020).
DOI:	10.1177/2333721420956751
Abstrakt:	Exercise is touted as the ideal prescription to treat and prevent many chronic diseases. We examined changes in utilization and cost of medication classes commonly prescribed in the management of chronic conditions following participation in 12-months of supervised exercise within the Veterans Affairs Gerofit program. Gerofit enrolled 480 veterans between 1999 and 2017 with 12-months participation, with 453 having one or more active prescriptions on enrollment. Active prescriptions overall and for five classes of medications were examined. Changes from enrollment to 12 months were calculated, and cost associated with prescriptions filled were used to estimate net cost changes. Active prescriptions were reduced for opioids (77 of 164, 47%), mental health (93 of 221, 42%), cardiac (175 of 391, 45%), diabetes (41 of 166, 25%), and lipid lowering (56 of 253, 22%) agents. Cost estimates resulted in a net savings of $38,400. These findings support the role of supervised exercise as a favorable therapeutic intervention that has impact across chronic conditions. Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2020.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu